Ceftriaxone-associated pseudolithiasis in hemodialysis patients: a case series study
Abstract Background Ceftriaxone, a third-generation cephalosporin, is widely used to treat bacterial infections in patients undergoing dialysis because it has a long half-life and broad spectrum of action and does not require dose reduction. However, renal dysfunction is a risk factor for ceftriaxon...
Guardado en:
| Autores principales: | , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
BMC
2021-02-01
|
| Colección: | Renal Replacement Therapy |
| Materias: | |
| Acceso en línea: | https://doi.org/10.1186/s41100-021-00320-4 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|